{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:29Z","timestamp":1791558089354,"version":"4.3.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003033","name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n Productiva","doi-asserted-by":"publisher","award":["FONCYT. PID 0031. Argentina"],"award-info":[{"award-number":["FONCYT. PID 0031. Argentina"]}],"id":[{"id":"10.13039\/501100003033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.00139","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T05:52:12Z","timestamp":1519624332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors"],"prefix":"10.3389","volume":"9","author":[{"given":"Rodolfo A.","family":"Kolliker Frers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanesa","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Kerzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Urdapilleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Chiocconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Kogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Otero-Losada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Capani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5312\/wjo.v5.i4.537","article-title":"Psoriatic arthritis: epidemiology, diagnosis, and treatment","volume":"5","author":"Liu","year":"2014","journal-title":"World J Orthop"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1172\/JCI200422147","article-title":"Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities","volume":"113","author":"Nickoloff","year":"2004","journal-title":"J Clin Invest"},{"key":"B3","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1529-8019.2008.01215.x","article-title":"Psoriatic arthritis","volume":"22","author":"Gladman","year":"2009","journal-title":"Dermatol Ther"},{"key":"B5","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.atherosclerosis.2008.08.039","article-title":"Atherosclerosis\u2014an immune disease. The Anitschkov Lecture 2007","volume":"202","author":"Hansson","year":"2009","journal-title":"Atherosclerosis"},{"key":"B7","first-page":"328","article-title":"Where the immune response meets the vessel wall","volume":"67","author":"Bisoendial","year":"2009","journal-title":"Neth J Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N","article-title":"Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death","volume":"41","author":"Gladman","year":"1998","journal-title":"Arthritis Rheum"},{"key":"B9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2133.2006.07562.x","article-title":"Psoriasis: a possible risk factor for development of coronary artery calcification","volume":"156","author":"Ludwig","year":"2007","journal-title":"Br J Dermatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","article-title":"Risk of myocardial infarction in patients with psoriasis","volume":"296","author":"Gelfand","year":"2006","journal-title":"JAMA"},{"key":"B11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/art.22884","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13075-016-1074-2","article-title":"The impact of identifying carotid plaque on addressing cardiovascular risk in psoriatic arthritis","volume":"18","author":"Lucke","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1038\/jid.2013.149","article-title":"Incidence of cardiovascular disease in individuals with psoriasis: a systematic review and meta-analysis","volume":"133","author":"Samarasekera","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3233\/DMA-2009-0646","article-title":"Markers of inflammation and risk of coronary heart disease","volume":"26","author":"Sarwar","year":"2009","journal-title":"Dis Markers"},{"key":"B15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/bja\/ael303","article-title":"Methods of detecting atherosclerosis in noncardiac surgical patients; the role of biochemical markers","volume":"97","author":"Howard-Alpe","year":"2006","journal-title":"Br J Anaesth"},{"key":"B16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcme.2015.01.005","article-title":"Psoriasis and cardiovascular risk: immune-mediated cross-talk between metabolic, vascular and autoimmune inflammation","volume":"6","author":"K\u00f6lliker Frers","year":"2015","journal-title":"IJC Metab Endocr"},{"key":"B17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.104.513085","article-title":"C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study","volume":"112","author":"Tzoulaki","year":"2005","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.3390\/ijms150711324","article-title":"Endothelial dysfunction in chronic inflammatory diseases","volume":"15","author":"Steyers","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.7150\/ijms.7.284","article-title":"Pathogenic mechanisms shared between psoriasis and cardiovascular disease","volume":"7","author":"Ghazizadeh","year":"2010","journal-title":"Int J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1016\/j.atherosclerosis.2007.04.053","article-title":"C-reactive protein and atherogenesis: from fatty streak to clinical event","volume":"195","author":"Bisoendial","year":"2007","journal-title":"Atherosclerosis"},{"key":"B21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1111\/jdv.12255","article-title":"Impact of systemic treatment of psoriasis on inflammatory parameters and markers of comorbidities and cardiovascular risk: results of a prospective longitudinal observational study","volume":"28","author":"Montaudi\u00e9","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1373\/clinchem.2011.168559","article-title":"Circulating soluble intercellular adhesion molecule 1 and subclinical atherosclerosis: the coronary artery risk development in young adults study","volume":"58","author":"Gross","year":"2012","journal-title":"Clin Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/j.jacc.2004.07.047","article-title":"Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis","volume":"44","author":"Deo","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1172\/JCI115411","article-title":"Monocyte chemoattractant protein-1 in human atheromatous plaques","volume":"88","author":"Nelken","year":"1991","journal-title":"J Clin Invest"},{"key":"B27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s11883-009-0021-y","article-title":"Monocyte chemoattractant protein (MCP-1)\/CCL2 as a biomarker in acute coronary syndromes","volume":"11","author":"Gonzalez-Quesada","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1089\/107999099314234","article-title":"Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease","volume":"19","author":"Krishnaswamy","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/09546634.2013.782091","article-title":"MCP-1 in psoriatic patients: effect of biological therapy","volume":"25","author":"Lembo","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s00296-015-3228-y","article-title":"Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity","volume":"35","author":"Yilmazer","year":"2015","journal-title":"Rheumatol Int"},{"key":"B31","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","article-title":"C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bcp.2009.04.029","article-title":"Inflammatory cytokines in vascular dysfunction and vascular disease","volume":"78","author":"Sprague","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: a comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5613056","DOI":"10.1155\/2016\/5613056","article-title":"Cardiorenal involvement in metabolic syndrome induced by cola drinking in rats: proinflammatory cytokines and impaired antioxidative protection","volume":"2016","author":"Otero-Losada","year":"2016","journal-title":"Mediators Inflamm"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1097\/HJH.0b013e328364ca4c","article-title":"2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH\/ESC Task Force for the Management of Arterial Hypertension","volume":"31","year":"2013","journal-title":"J Hypertens"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0002-9343(84)90952-5","article-title":"Epidemiology of coronary heart disease: the Framingham Study","volume":"76","author":"Castelli","year":"1984","journal-title":"Am J Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/art.22531","article-title":"The disease activity score in 28 joints in rheumatoid arthritis and psoriatic arthritis patients","volume":"57","author":"Leeb","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B41","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease scores that include twenty-eight joint counts. Development and validation in prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/ard.62.7.681","article-title":"Twenty-eight joint count disease activity score in recent onset rheumatoid arthritis using C reactive protein instead of erythrocyte sedimentation rate","volume":"62","author":"Skogh","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis: oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1056\/NEJMoa032804","article-title":"C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease","volume":"350","author":"Danesh","year":"2004","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(01)06104-9","article-title":"Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis","volume":"358","author":"Malik","year":"2001","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.4330\/wjc.v6.i6.455","article-title":"Metabolic, autonomic and immune markers for cardiovascular disease in posttraumatic stress disorder","volume":"6","author":"Kibler","year":"2014","journal-title":"World J Cardiol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1007\/s00125-015-3618-4","article-title":"GIP increases adipose tissue expression and blood levels of MCP-1 in humans and links high energy diets to inflammation: a randomised trial","volume":"58","author":"G\u00f6gebakan","year":"2015","journal-title":"Diabetologia"},{"key":"B48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S1995-7645(14)60098-5","article-title":"Effect of pharmacological intervention on MIP-1\u03b1, MIP-1\u03b2 and MCP-1 expression in patients with psoriasis vulgaris","volume":"7","author":"Dai","year":"2014","journal-title":"Asian Pac J Trop Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/01.RES.0000165803.47776.38","article-title":"Adipocyte signalling and lipid homeostasis: sequelae of insulin-resistant adipose tissue","volume":"96","author":"Yu","year":"2005","journal-title":"Circ Res"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.ijo.0803032","article-title":"Regulation of monocyte chemoattractant protein 1 (MCP-1) release by explants of human visceral adipose tissue","volume":"29","author":"Fain","year":"2005","journal-title":"Int J Obes"},{"key":"B51","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.smim.2015.10.006","article-title":"Interactions between adipose tissue and the immune system in health and malnutrition","volume":"27","author":"Wensveen","year":"2015","journal-title":"Semin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.bbrc.2004.03.090","article-title":"Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and interleukin-6 in 3T3-1 adipocytes","volume":"317","author":"Fasshauer","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1002\/jcp.20134","article-title":"Upregulation of TNF-alpha-induced ICAM-1 surface expression by adenylate cyclase-dependent pathway in human endothelial cells","volume":"202","author":"Bernot","year":"2005","journal-title":"J Cell Physiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/hep.1840220326","article-title":"Differential expression and release of CD54 induced by cytokines","volume":"22","author":"Mickelson","year":"1995","journal-title":"Hepatology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/VHRM.S104369","article-title":"Triglyceride-rich lipoproteins as a causal factor for cardiovascular disease","volume":"12","author":"Toth","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"B56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2340\/00015555-0510","article-title":"Psoriasis and dyslipidaemia: a population-based study","volume":"88","author":"Dreiher","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis inpatients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"B58","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case-control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e3322","DOI":"10.1097\/MD.0000000000003322","article-title":"Risk factors associated with increased carotid intima-media thickness in a male population with chronic alcohol consumption: a prospective observational study","volume":"95","author":"Qu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.7860\/JCDR\/2014\/7588.4000","article-title":"Apo B\/Apo A-I ratio is statistically a better predictor of cardiovascular disease (CVD) than conventional lipid profile: a study from Kathmandu Valley, Nepal","volume":"8","author":"Tamang","year":"2014","journal-title":"J Clin Diagn Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00139\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T05:52:16Z","timestamp":1519624336000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2018.00139\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2018.00139"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.00139","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"article-number":"139"}}